In vitro effect of the coronary vasodilator diltiazem on human and rabbit platelets.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D001095:Arachidonic Acids / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D001552:Benzazepines / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects*; D002118:Calcium / Q000494:pharmacology; D003094:Collagen / Q000494:pharmacology; D004110:Diltiazem / Q000494:pharmacology*; D004533:Egtazic Acid / Q000494:pharmacology; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects; D011817:Rabbits; D014665:Vasodilator Agents / Q000494:pharmacology*
D001095:Arachidonic Acids; D001552:Benzazepines; D014665:Vasodilator Agents; D004533:Egtazic Acid; D000244:Adenosine Diphosphate; D003094:Collagen; D004110:Diltiazem; D001241:Aspirin; D002118:Calcium; D007213:Indomethacin